Expert consensus post-marketing evaluation scheme to detect immunotoxicity of Chinese medicine in clinical populations (draft version for comments) / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 2933-2936, 2013.
Article
Dans Zh
| WPRIM
| ID: wpr-238579
Responsable en Bibliothèque :
WPRO
ABSTRACT
Through consensus, establish a post-marketing scheme and the technical processes to evaluate Chinese medicine's immunotoxicity on a population, as well as its beneficial influences on the immune system. Provide regulations on the collection, storage and transportation of serum samples. This article applies to the post-marketing scientific evaluation of the immunotoxicity of parenterally administered, and for other ways of taking Chinese medicine.
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Surveillance post-commercialisation des produits de santé
/
Normes de référence
/
Médicaments issus de plantes chinoises
/
Techniques immunologiques
/
Surveillance des médicaments
/
Lymphocytes auxiliaires Th2
/
Lymphocytes auxiliaires Th1
/
Consensus
/
Hypersensibilité médicamenteuse
/
Allergie et immunologie
Type d'étude:
Guideline
Limites du sujet:
Humans
langue:
Zh
Texte intégral:
China Journal of Chinese Materia Medica
Année:
2013
Type:
Article